Key result
The EUROACTION nurse-managed prevention program reduced the 12-year risk of death by 36% compared to usual care in combined CHD and high-risk patients (HR 0.64; 95% CI 0.48-0.86).
Why the study?
The EUROACTION study showed the efficacy of a nurse-managed prevention program in reducing cardiovascular risk factors, but information on survival was lacking.
Does a nurse-coordinated multidisciplinary cardiovascular disease prevention program improve lifestyle, risk factors, and survival in patients with coronary heart disease and high-risk patients?
Population
628 patients with CHD and 711 high-risk patients in Poland
Comparison
EUROACTION nurse-managed comprehensive prevention program vs usual care
Design
Cluster-randomized trial
Follow-up
12 years
Authors
Loading...
May support sustained nurse-led prevention despite unsustained risk factor gains; leaves open confirmation in larger trials.
RCT (n=1,339)
randomly allocated
Yes
Does a nurse-coordinated multidisciplinary cardiovascular disease prevention program improve lifestyle, risk factors, and survival in patients with coronary heart disease and high-risk patients?
Hazard Ratio: 0.64 (95% CI 0.48–0.86)
A nurse-coordinated multidisciplinary prevention program improved 1-year risk factors and was associated with significantly improved 12-year survival in CHD and high-risk patients.
Pająk et al. (2020) conducted an RCT in Coronary heart disease and high cardiovascular risk (n=1,339). EUROACTION nurse-managed comprehensive cardiovascular disease prevention program vs. Usual care was evaluated on Lifestyle and risk factors changes at 1-year follow-up; death at 12 years (HR 0.64, 95% CI 0.48-0.86). The EUROACTION nurse-managed prevention program reduced the 12-year risk of death by 36% compared to usual care in combined CHD and high-risk patients (HR 0.64; 95% CI 0.48-0.86).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: